AU2001239736A1 - Use of thiostrepton as an anti-mycobacterial agent - Google Patents

Use of thiostrepton as an anti-mycobacterial agent

Info

Publication number
AU2001239736A1
AU2001239736A1 AU2001239736A AU3973601A AU2001239736A1 AU 2001239736 A1 AU2001239736 A1 AU 2001239736A1 AU 2001239736 A AU2001239736 A AU 2001239736A AU 3973601 A AU3973601 A AU 3973601A AU 2001239736 A1 AU2001239736 A1 AU 2001239736A1
Authority
AU
Australia
Prior art keywords
thiostrepton
mycobacterial agent
mycobacterial
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239736A
Inventor
Mary W. Vermeulen
Jiaya Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of AU2001239736A1 publication Critical patent/AU2001239736A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001239736A 2000-01-31 2001-01-31 Use of thiostrepton as an anti-mycobacterial agent Abandoned AU2001239736A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17920300P 2000-01-31 2000-01-31
US60179203 2000-01-31
PCT/US2001/003136 WO2001054693A1 (en) 2000-01-31 2001-01-31 Use of thiostrepton as an anti-mycobacterial agent

Publications (1)

Publication Number Publication Date
AU2001239736A1 true AU2001239736A1 (en) 2001-08-07

Family

ID=22655649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239736A Abandoned AU2001239736A1 (en) 2000-01-31 2001-01-31 Use of thiostrepton as an anti-mycobacterial agent

Country Status (5)

Country Link
US (1) US20040254100A1 (en)
EP (1) EP1255548A4 (en)
JP (1) JP2003520815A (en)
AU (1) AU2001239736A1 (en)
WO (1) WO2001054693A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697653B2 (en) * 2010-08-05 2014-04-15 Priamal Enterprises Limited Microparticle formulation for pulmonary drug delivery of anti infective molecule for treatment of infectious diseases
CN106636167A (en) * 2016-10-17 2017-05-10 中国科学院广州生物医药与健康研究院 Thiostrepton-gentamicin resistance gene system as well as resistance expression box and recombinant plasmid containing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2982689A (en) * 1955-03-01 1961-05-02 Olin Mathieson Thiostrepton, its salts, and production
GB790521A (en) * 1955-11-15 1958-02-12 Bristol Lab Inc Improvements in or relating to antibiotics
US3082153A (en) * 1960-11-10 1963-03-19 Shionogi & Co Antibiotic siomycin and a method of producing same

Also Published As

Publication number Publication date
JP2003520815A (en) 2003-07-08
WO2001054693A1 (en) 2001-08-02
EP1255548A4 (en) 2004-10-06
EP1255548A1 (en) 2002-11-13
US20040254100A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001291859A1 (en) Use of copolycarbonates
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2001267064A1 (en) Surgical table
AU2731302A (en) Use of cci-779 as an antineoplastic agent
AU2001295657A1 (en) Formulation containing wax-esters
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001247300A1 (en) Nystatin formulation having reduced toxicity
EP1151667A3 (en) Plant-activating agent
AU2001283344A1 (en) Dermatological formulation
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002222148A1 (en) Preparation of spheroids
AU2002214038A1 (en) Inhibitors of transglutaminases
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001266124A1 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU2001239736A1 (en) Use of thiostrepton as an anti-mycobacterial agent
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001262148A1 (en) Use of 3-iodine-2-propinyl-carbamates as antimicrobial active agent
AUPR099200A0 (en) New formulation
AU2001275696A1 (en) Therapeutic agent
EP1199076A3 (en) Medicament containing tocotrienol as active component
AU2001272490A1 (en) Use of galiella lactone
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue